UK MPs urge govt not to abolish embryology research regulator
This article was originally published in RAJ Devices
Several Members of Parliament in the UK have urged the government to reconsider its plans to abolish the Human Fertilisation and Embryology Authority, saying it is a priceless resource that must be retained and sustained for the future1.
You may also be interested in...
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.